Difficulty: Medium
Average Score: 79%
Practice
Your patient is receiving basiliximab and develops cytokine release syndrome. You would expect to see:
Correct answer
B
Rationale
The correct answer is B: Chills. Basiliximab is a monoclonal antibody used to prevent organ rejection by suppressing the immune system. Cytokine release syndrome is a common side effect characterized by the rapid release of cytokines, leading to symptoms such as fever, chills, and flu-like symptoms. Chills specifically indicate an acute systemic inflammatory response, which is a hallmark of cytokine release syndrome. The other choices (A: Coughing, C: Tremors, D: Weakness) are not typically associated with cytokine release syndrome.